<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.15805.2</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Clinical Practice Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Visceral leishmaniasis (Kala-azar) in Qom Province, Iran: Report of two cases</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 2; peer review: 2 approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Zanjirani Farahani</surname>
                        <given-names>Leyli</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-7397-5605</uri>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Saghafipour</surname>
                        <given-names>Abedin</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Mohebali</surname>
                        <given-names>Mehdi</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="corresp" rid="c2">b</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Akhoundi</surname>
                        <given-names>Behnaz</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Raufi</surname>
                        <given-names>Hedayatollah</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Medical Parasitology and Mycology, Tehran University of Medical Sciences, Tehran, Iran</aff>
                <aff id="a2">
                    <label>2</label>Department of Public Health, Qom University of Medical Sciences, Qom, Iran</aff>
                <aff id="a3">
                    <label>3</label>Health Center of Qom Province, Qom University of Medical Sciences, Qom, Iran</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:abed.saghafi@yahoo.com">abed.saghafi@yahoo.com</email>
                </corresp>
                <corresp id="c2">
                    <label>b</label>
                    <email xlink:href="mailto:mohebali@tums.ac.ir">mohebali@tums.ac.ir</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>22</day>
                <month>5</month>
                <year>2019</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2018</year>
            </pub-date>
            <volume>7</volume>
            <elocation-id>1371</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>15</day>
                    <month>5</month>
                    <year>2019</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Zanjirani Farahani L et al.</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/7-1371/pdf"/>
            <abstract>
                <p>Visceral leishmaniasis (VL) is a fatal parasitic zoonotic worldwide disease, which transmits to humans by the infected 
                    <italic toggle="yes">Phlebotomine</italic> sand fly bite. The common form of VL in Iran is the Mediterranean type with the causative agent of 
                    <italic toggle="yes">Leishmania infantum</italic>, whose main reservoirs are stray and domesticated dogs. The disease has several endemic foci in Iran, mostly seen among children under the age of 10, living in rural areas and nomadic tribes. The first cases of Kala-Azar in Qom province, central Iran, were reported in the year 2001, from the villages of Ghahan district. After conducting VL control strategies in the area, no new cases of the disease had been reported until recently. The cases described here are two 2-year-old girls, living in the urban parts of Qom province, one of whom did not have a history of traveling to known endemic areas of the disease. The patients were admitted to hospital in 2016&#x2013;2017, complaining from recurrent fever with unrecognized reason, associated with decreased appetite and weight loss. Disease follow-up demonstrated anemia and splenomegaly, which led to diagnosis of VL, and both patients are now fully recovered. VL was presumed to be controlled in Qom province but the present cases indicate that possible VL existence remains in the region. Therefore, urgent studies and periodic monitoring are needed to identify potential reservoirs of VL in the area.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Visceral leishmaniasis</kwd>
                <kwd>Kala-azar</kwd>
                <kwd>Qom</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1">
                    <funding-source>Tehran University of Medical Sciences</funding-source>
                </award-group>
                <funding-statement>This study was part of MSc thesis No. 240/221, financially supported by Tehran University of Medical Sciences.</funding-statement>
                <funding-statement>
                    <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
                </funding-statement>
            </funding-group>
        </article-meta>
        <notes>
            <sec sec-type="version-changes">
                <label>Revised</label>
                <title>Amendments from Version 1</title>
                <p>Table 1 is&#x00a0;corrected as the reviewer advised. The Introduction is&#x00a0;revised and the first phrase is corrected. We tried to add more information about the presented cases according to the existing documents.&#x00a0; A figure of the bone marrow slide is added (Figure 2),&#x00a0;showing the amastigotes&#x00a0;of Leishmania parasite within a macrophage. We tried to do our best to change and complete the discussion part based on the reviewers&#x2019; advice.</p>
            </sec>
        </notes>
    </front>
    <body>
        <sec sec-type="intro">
            <title>Introduction</title>
            <p> Human parasitic infections are important  health issues due to insufficient epidemiological studies and lack of adequate information on the aspects of diagnosis and treatment. Problems caused by parasitic diseases in different regions have their own special characteristics. Visceral leishmaniasis (VL) or Kala-azar is one of the most severe zoonotic diseases caused by different species of 
                <italic toggle="yes">Leishmania,</italic> which leads to death in 95% of cases if not treated
                <sup>
                    <xref ref-type="bibr" rid="ref-1">1</xref>
                </sup>. An estimated 50,000&#x2013;90,000 new cases of VL occur worldwide annually
                <sup>
                    <xref ref-type="bibr" rid="ref-2">2</xref>
                </sup>. VL has been linked to hygiene and environmental health, along with malnutrition, weak immune system and population displacement considerations. VL is commonly observed in children in the under 10 year age group, especially 1&#x2013;5 year-olds, but also afflicts adults suffering from immunodeficiency
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup>. The zoonotic form of VL is caused by 
                <italic toggle="yes">Leishmania infantum</italic> whose pathogenic form transmits from the animal reservoir to humans through infected 
                <italic toggle="yes">Phlebotominae</italic> sand fly bites. The parasite&#x2019;s natural reservoirs are dogs, wild canids, foxes,  jackals and occasionally wolves
                <sup>
                    <xref ref-type="bibr" rid="ref-4">4</xref>
                </sup>.</p>
            <p>VL is seen most commonly in rural areas and clinical symptoms vary from asymptomatic forms and restricted infection to lethal VL. Disease incubation period lasts from a few weeks to several months
                <sup>
                    <xref ref-type="bibr" rid="ref-5">5</xref>
                </sup>. In Iran, fever and anemia have been reported as the most common clinical signs and hepatosplenomegaly is generally displayed six months after the onset of the infection. Bone marrow involvement causes severe anemia and cachexia in the patient. Finally, secondary bacterial infections can result in the patient's death. VL clinical diagnosis is difficult due to nonspecific symptoms similar to other diseases, such as malaria, typhoid fever, brucellosis, lymphoma and leukemia, especially in non-endemic regions
                <sup>
                    <xref ref-type="bibr" rid="ref-5">5</xref>,
                    <xref ref-type="bibr" rid="ref-6">6</xref>
                </sup>.</p>
            <p>Between 1998 and 2012 in Iran, 2632 cases of VL were recorded, with the majority of cases in the northern and southern parts of the country. The highest number of cases were in April and July in the age group 1&#x2013;3 years and the annual average over the 14-year period was 175.4 cases. While the peak incidence was recorded in 2000 (13.15% of total leishmaniasis cases), VL occurrence decreased in the following years. The first cases of VL in Qom province were  reported  in 2001 and no new case has been reported until recently
                <sup>
                    <xref ref-type="bibr" rid="ref-5">5</xref>
                </sup>.</p>
            <p>In this Clinical Practice Article, two cases of Kala-azar are reported, which were detected in Hazrat-E-Masoumeh Hospital in Qom Province, Iran, in 2016 and 2017.</p>
        </sec>
        <sec sec-type="cases">
            <title>Case 1</title>
            <p>In February 2016 a 22-month-old girl, who was living in Qom&#x2019;s downtown, was admitted to Hazrate-E-Masoume Hospital with irregular prolonged fever, cough and loss of appetite for about one month. In the initial follow-up, the cause of fever remained unrecognized and the patient was referred to the hospital, accordingly. Based on her parent&#x2019;s statement, the child had travelled to Dastgerd village, in Kahak district, south of Qom Province, in November 2016, two months before clinical signs appear.</p>
            <p>In early clinical examinations, the patient&#x2019;s throat, ears, heart and lungs were functioning normally. Abdominal ultrasonography showed normal liver tissue and enlarged spleen with diffused nodules and 14.5 mm spleen span (
                <xref ref-type="fig" rid="f1">Figure 1</xref>). Blood smear examination showed hypochromic microcytic anemia with white blood cell and platelet number reduction (
                <xref ref-type="table" rid="T1">Table 1</xref>).</p>
            <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                <label>Figure 1. </label>
                <caption>
                    <p>Ultrasound scan of enlarged spleen in (
                        <bold>A</bold>) Case 1and (
                        <bold>B</bold>) Case 2.</p>
                </caption>
                <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/21218/c595c9cc-6ac4-44fe-a5a3-f68d79c51e55_figure1.gif"/>
            </fig>
            <table-wrap id="T1" orientation="portrait" position="anchor">
                <label>Table 1. </label>
                <caption>
                    <title>Laboratory blood test results of the cases on admittance and one month after treatment.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="center" colspan="1" rowspan="1"/>
                            <th align="center" colspan="2" rowspan="1">Case 1</th>
                            <th align="center" colspan="2" rowspan="1">Case 2</th>
                            <th align="center" colspan="1" rowspan="1"/>
                        </tr>
                        <tr>
                            <th align="center" colspan="1" rowspan="1"/>
                            <th align="center" colspan="1" rowspan="1">Before
                                <break/>diagnosis</th>
                            <th align="center" colspan="1" rowspan="1">One month after
                                <break/>treatment</th>
                            <th align="center" colspan="1" rowspan="1">Before
                                <break/>diagnosis</th>
                            <th align="center" colspan="1" rowspan="1">one month after
                                <break/>treatment</th>
                            <th align="center" colspan="1" rowspan="1">Normal range</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="center" colspan="1" rowspan="1">Hemoglobin (g/dl)</td>
                            <td align="center" colspan="1" rowspan="1">10.5</td>
                            <td align="center" colspan="1" rowspan="1">11.2</td>
                            <td align="center" colspan="1" rowspan="1">8.9</td>
                            <td align="center" colspan="1" rowspan="1">12</td>
                            <td align="center" colspan="1" rowspan="1">11&#x2013;14</td>
                        </tr>
                        <tr>
                            <td align="center" colspan="1" rowspan="1">Hematocrit (%)</td>
                            <td align="center" colspan="1" rowspan="1">28</td>
                            <td align="center" colspan="1" rowspan="1">31</td>
                            <td align="center" colspan="1" rowspan="1">25</td>
                            <td align="center" colspan="1" rowspan="1">33</td>
                            <td align="center" colspan="1" rowspan="1">31&#x2013;41</td>
                        </tr>
                        <tr>
                            <td align="center" colspan="1" rowspan="1">Leukocytes (/mm
                                <sup>3</sup>)</td>
                            <td align="center" colspan="1" rowspan="1">3400</td>
                            <td align="center" colspan="1" rowspan="1">6600</td>
                            <td align="center" colspan="1" rowspan="1">2900</td>
                            <td align="center" colspan="1" rowspan="1">6200</td>
                            <td align="center" colspan="1" rowspan="1">6000&#x2013;17000</td>
                        </tr>
                        <tr>
                            <td align="center" colspan="1" rowspan="1">Neutrophil (%)</td>
                            <td align="center" colspan="1" rowspan="1">35</td>
                            <td align="center" colspan="1" rowspan="1">34</td>
                            <td align="center" colspan="1" rowspan="1">30</td>
                            <td align="center" colspan="1" rowspan="1">35</td>
                            <td align="center" colspan="1" rowspan="1">35&#x2013;80</td>
                        </tr>
                        <tr>
                            <td align="center" colspan="1" rowspan="1">Lymphocyte (%)</td>
                            <td align="center" colspan="1" rowspan="1">62</td>
                            <td align="center" colspan="1" rowspan="1">56</td>
                            <td align="center" colspan="1" rowspan="1">66</td>
                            <td align="center" colspan="1" rowspan="1">60</td>
                            <td align="center" colspan="1" rowspan="1">35&#x2013;80</td>
                        </tr>
                        <tr>
                            <td align="center" colspan="1" rowspan="1">Platelet count
                                <break/>(/mm
                                <sup>3</sup>)</td>
                            <td align="center" colspan="1" rowspan="1">118000</td>
                            <td align="center" colspan="1" rowspan="1">252000</td>
                            <td align="center" colspan="1" rowspan="1">83000</td>
                            <td align="center" colspan="1" rowspan="1">285000</td>
                            <td align="center" colspan="1" rowspan="1">150000&#x2013;400000</td>
                        </tr>
                        <tr>
                            <td align="center" colspan="1" rowspan="1">ESR (mm/hour)</td>
                            <td align="center" colspan="1" rowspan="1">82</td>
                            <td align="center" colspan="1" rowspan="1">50</td>
                            <td align="center" colspan="1" rowspan="1">110</td>
                            <td align="center" colspan="1" rowspan="1">62</td>
                            <td align="center" colspan="1" rowspan="1">0&#x2013;10</td>
                        </tr>
                        <tr>
                            <td align="center" colspan="1" rowspan="1">CRP</td>
                            <td align="center" colspan="1" rowspan="1">1+</td>
                            <td align="center" colspan="1" rowspan="1">Negative</td>
                            <td align="center" colspan="1" rowspan="1">2+</td>
                            <td align="center" colspan="1" rowspan="1">Negative</td>
                            <td align="center" colspan="1" rowspan="1">Negative</td>
                        </tr>
                    </tbody>
                </table>
            </table-wrap>
            <p>Serological tests for human immunodeficiency virus (HIV), hepatitis and malaria showed negative results. Blood culture, tuberculin test and thoracic radiography showed no specific cause for the fever. Due to associated fever with enlargement of the spleen and pancytopenia, Direct Agglutination Test (DAT) was performed to detect anti-Leishmania antibodies, which showed positive result with a high titer of anti-
                <italic toggle="yes">L. infantum</italic> antibodies as 1:6400 which was confirmed with Indirect Immunofluorescence Assay (IFA&gt;1:640).</p>
            <p>After diagnosis, Amphotericin-B injection was prescribed at 1 mg/kg for the first day, increased to 5 mg/kg during one week. The last dose was continued until day 10. As soon as treatment began, the patient&#x2019;s fever reduced and the patient&#x2019;s general state improved. In the next follow-up, two weeks later, the blood cell count had risen and the patient was considered successfully treated.</p>
        </sec>
        <sec sec-type="cases">
            <title>Case 2</title>
            <p>In April 2017 a 26-month-old girl was admitted to Hazrat-E-Masoumeh Hospital in Qom. The patient lived in Qom city, and had no history of travelling to VL endemic regions since she was born. The patient presented with an unknown, persistent fever, anorexia, and general weakness, which had started four months ago, not responding to antibiotic therapy. The patient had some bruises on her abdomen and legs that appeared a month earlier, which caused the physicians to suspect anemia and leukemia.</p>
            <p>Ultrasonography demonstrated mild enlargement of the spleen (
                <xref ref-type="fig" rid="f1">Figure 1</xref>). Examinations showed reduction in all blood elements (
                <xref ref-type="table" rid="T1">Table 1</xref>). The results of typical serological tests were negative. Bone marrow aspiration was evaluated because of pancytopenia in which no blast cell was seen. Then, due to observation of amastigotes of 
                <italic toggle="yes">Leishmania</italic> parasite (Leishman-Donovan bodies) within bone marrow macrophages, and the positive DAT result (&gt;1:3200), visceral leishmaniasis was diagnosed (
                <xref ref-type="fig" rid="f2">Figure 2</xref>). Therefore, Amphotericin-B treatment was initiated with dose of 1 mg/kg for 21 days. After four days, the patient's fever disappeared, her general condition improved and blood cell number increased at the next month follow-up.</p>
            <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                <label>Figure 2. </label>
                <caption>
                    <title>Bone marrow aspiration of case 2, showing Leishmania amastigots within macrophage.</title>
                </caption>
                <graphic orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/21218/c595c9cc-6ac4-44fe-a5a3-f68d79c51e55_figure2.gif"/>
            </fig>
        </sec>
        <sec sec-type="discussion">
            <title>Discussion</title>
            <p>Visceral leishmaniasis (VL) is endemic in some provinces of Iran, including Ardebil, East Azarbaijan, Bushehr, Fars, and North Khorasan, and sporadically occurs in other provinces. The first human VL case in Iran was observed in Northern Iran in 1949
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup>. In Qom province, the first VL cases were observed in 2001, during the study by Fakhar 
                <italic toggle="yes">et al.</italic>, in which 1.7% of 416 serum samples were diagnosed seropositive, and was related to 25% contamination of dogs in rural districts of Ghahan, a northwestern part of the province
                <sup>
                    <xref ref-type="bibr" rid="ref-7">7</xref>
                </sup>.</p>
            <p>This article reports the first cases of Kala-azar in urban areas of Qom province. So far, over 95% of the cases in Iran have been from rural areas
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup>. Despite the history of traveling to a village in the first case presented here, the disease may not be linked to the village definitely. The probability of there being more patients in Qom province and referring them to hospitals out of the province requires further investigation.</p>
            <p>Kala-azar is frequently misdiagnosed because of nonspecific symptoms. Also false negative results of serologic and microscopic examinations in the disease early stages, make the diagnosis an important issue, in non-endemic areas. Due to the lack of knowledge about VL, the cases were referred to hospital a few months after the onset of symptoms. Therefore, there is not enough available history of children like the presence of malnutrition or other underlying illness which may affect the immune system of cases.</p>
            <p>The symptoms of VL are related to involvement of the reticuloendothelial system, which includes enlargement of the spleen, liver and lymph nodes. Moreover, bone marrow infection leads to a decrease in its normal activity, resulting in anemia, leukopenia, and thrombocytopenia
                <sup>
                    <xref ref-type="bibr" rid="ref-6">6</xref>
                </sup>. The common symptoms in the present patients were intermittent fever, pancytopenia and splenomegaly. In previous studies, the main hallmarks of the disease were persistent fever, pallor, and spleen and liver enlargement
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup>. Spleen enlargement is also seen in other infections like CMV, toxoplasmosis, mononucleosis, tuberculosis, malaria and hematological disorders. In the present cases no hepatomegaly was observed. Normochromic normocytic anemia and pancytopenia (decrease of all blood cell types) were features of identified anemia in patients in this report. The incubation period in VL varies from two weeks to several months. In one quarter of VL cases, VL develops actively and symptoms appear between 2&#x2013;8 months after parasite entrance to the body
                <sup>
                    <xref ref-type="bibr" rid="ref-6">6</xref>,
                    <xref ref-type="bibr" rid="ref-8">8</xref>
                </sup>. There is no obvious evidence of exposure to the parasite in the cases presented here, although in the first case it can be attributed to the child&#x2019;s visit to the villages of Qom. The role of domestic or stray dogs and 
                <italic toggle="yes">Phlebotominae</italic> sand flies in transmission cycle of the disease in clear
                <sup>
                    <xref ref-type="bibr" rid="ref-4">4</xref>
                </sup>. None of the patient families had dogs but more research is needed to check the stray dogs infection. </p>
            <p>DAT and IFA serology methods are considered the most efficient diagnostic tests for Kala-azar. The definitive infection diagnosis  is done through parasitological methods involving microscopic examination of spleen, bone marrow and lymph nodes aspiration to observe the parasite, which are sensitive but invasive and potentially hazardous
                <sup>
                    <xref ref-type="bibr" rid="ref-9">9</xref>
                </sup>. Evaluation of indirect IFA and DAT showed that IFA is more reliable in VL diagnosis than DAT but needs advanced laboratory equipment, while DAT is a simple, precise, cost effective and applicable test for all situations
                <sup>
                    <xref ref-type="bibr" rid="ref-10">10</xref>
                </sup>. Due to the possibility of cross-reaction between VL and cutaneous leishmaniasis, tuberculosis and malaria in performing DAT, the history of such diseases in the patient should be investigated as well as any blood transfusion history or congenital transmission. Upon referral of the first patient reported here, both DAT and IFA results were positive. Since false positive results are likely in DAT method, it is advised to be confirmed by using a definitive parasitology method such as bone marrow aspiration, which was performed in the second patient.</p>
            <p>In a VL reservoir study in Iran, not only stray dogs, but also domestic dogs have been infected with 
                <italic toggle="yes">Leishmania</italic> parasite. In 2012&#x2013;2014, asymptomatic and symptomatic domestic dogs were compared in Meshkin-shahr; 18.6% of asymptomatic domestic dogs had VL infection, and surprisingly, 13.4% of the asymptomatic dogs demonstrated negative serology tests while they had been positive in the parasitology exam. Therefore, the presence of domesticated and stray dogs in urban and rural areas play an important role in the occurrence of sporadic cases of VL
                <sup>
                    <xref ref-type="bibr" rid="ref-11">11</xref>,
                    <xref ref-type="bibr" rid="ref-12">12</xref>
                </sup>. Because of the complex nature of VL manifestations and the risk of misdiagnosis, physicians in urban and rural health centers should remain vigilant, as they play a crucial role in early diagnosis and timely treatment of patients
                <sup>
                    <xref ref-type="bibr" rid="ref-13">13</xref>
                </sup>.</p>
            <p>In Qom Province, central Iran, Kala-azar had presumably been controlled after control strategies were implemented, and no new cases had been reported recently. The two cases in this report indicate that VL might not be eradicated totally in this area. Therefore, further studies on epidemiological aspects of 
                <italic toggle="yes">Leishmania</italic> reservoirs and vectors are recommended along with increased surveillance system awareness.</p>
        </sec>
        <sec>
            <title>Consent</title>
            <p>Written informed consent for the publication of clinical details of the patients described here was obtained from their parents.</p>
        </sec>
        <sec>
            <title>Data availability</title>
            <p>All data underlying the results are available as part of the article and no additional source data are required.</p>
        </sec>
    </body>
    <back>
        <ack>
            <title>Acknowledgments</title>
            <p>We thank the kindly cooperation of the officials in Hazrat-E-Masoumeh Hospital in Qom, Iran, and Qom province Health Center staff as well as Leishmaniasis Laboratory coworkers at the Medical Parasitology and Mycology Department of Tehran University of Medical Sciences, Tehran, Iran, in the preparation of this report.</p>
        </ack>
        <ref-list>
            <ref id="ref-1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <collab>World Health Organization</collab>:
                    <article-title>Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, March 22&#x2013;26, 2010.</article-title>
                    <source>

                        <italic toggle="yes">World Health Organ Tech Rep Ser.</italic>
</source>
                    <year>2010</year>;<volume>949</volume>:<fpage>1</fpage>&#x2013;<lpage>186</lpage>.
                    <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/44412/WHO_TRS_949_eng.pdf?sequence=1">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <collab>World Health Organization</collab>:
                    <article-title>Leishmaniasis page: Home/ News/ Fact sheets. </article-title>
                    <year>2018</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://www.who.int/news-room/fact-sheets/detail/leishmaniasis">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mohebali</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Edrissian</surname>
                            <given-names>GH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Shirzadi</surname>
                            <given-names>MR</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>An observational study on the current distribution of visceral leishmaniasis in different geographical zones of Iran and implication to health policy.</article-title>
                    <source>

                        <italic toggle="yes">Travel Med Infect Dis.</italic>
</source>
                    <year>2011</year>;<volume>9</volume>(<issue>2</issue>):<fpage>67</fpage>&#x2013;<lpage>74</lpage>.
                    <pub-id pub-id-type="pmid">21419708</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.tmaid.2011.02.003</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Yaghoobi-Ershadi</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>Phlebotomine Sand Flies (Diptera: Psychodidae) in Iran and their Role on 
                        <italic toggle="yes">Leishmania</italic> Transmission.</article-title>
                    <source>

                        <italic toggle="yes">J Arthropod Borne Dis.</italic>
</source>
                    <year>2012</year>;<volume>6</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>17</lpage>.
                    <pub-id pub-id-type="pmid">23293774</pub-id>
                    <pub-id pub-id-type="pmcid">3528173</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Shirzadi</surname>
                            <given-names>MR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Esfahania</surname>
                            <given-names>SB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mohebalia</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Epidemiological status of leishmaniasis in the Islamic Republic of Iran, 1983-2012.</article-title>
                    <source>

                        <italic toggle="yes">East Mediterr Health J.</italic>
</source>
                    <year>2015</year>;<volume>21</volume>(<issue>10</issue>):<fpage>736</fpage>&#x2013;<lpage>42</lpage>.
                    <pub-id pub-id-type="pmid">26750164</pub-id>
                    <pub-id pub-id-type="doi">10.26719/2015.21.10.736</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>McGwire</surname>
                            <given-names>BS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Satoskar</surname>
                            <given-names>AR</given-names>
                        </name>
</person-group>:
                    <article-title>Leishmaniasis: clinical syndromes and treatment.</article-title>
                    <source>

                        <italic toggle="yes">QJM.</italic>
</source>
                    <year>2014</year>;<volume>107</volume>(<issue>1</issue>):<fpage>7</fpage>&#x2013;<lpage>14</lpage>.
                    <pub-id pub-id-type="pmid">23744570</pub-id>
                    <pub-id pub-id-type="doi">10.1093/qjmed/hct116</pub-id>
                    <pub-id pub-id-type="pmcid">3869292</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Fakhar</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mohebali</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Barani</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>Identification of endemic focus of kala-azar and seroepidemiological study of visceral leishmaniasis infection in human and canine in Qom province, Iran.</article-title>
                    <source>

                        <italic toggle="yes">Armaghane Danesh.</italic>
</source>
                    <year>2004</year>;<volume>9</volume>(<issue>33</issue>):<fpage>43</fpage>&#x2013;<lpage>52 (Persian)</lpage>.
                    <ext-link ext-link-type="uri" xlink:href="http://armaghanj.yums.ac.ir/article-1-857-en.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chappuis</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sundar</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hailu</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?</article-title>
                    <source>

                        <italic toggle="yes">Nat Rev Microbiol.</italic>
</source>
                    <year>2007</year>;<volume>5</volume>(<issue>11</issue>):<fpage>873</fpage>&#x2013;<lpage>82</lpage>.
                    <pub-id pub-id-type="pmid">17938629</pub-id>
                    <pub-id pub-id-type="doi">10.1038/nrmicro1748</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mohebali</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Edrissian</surname>
                            <given-names>GhH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nadim</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Application of direct agglutination test (DAT) for the diagnosis and seroepidemiological studies of visceral leis-hmaniasis in Iran.</article-title>
                    <source>

                        <italic toggle="yes">Iranian J Parasitol.</italic>
</source>
                    <year>2006</year>;<volume>1</volume>(<issue>1</issue>):<fpage>15</fpage>&#x2013;<lpage>25</lpage>.
                    <ext-link ext-link-type="uri" xlink:href="https://pdfs.semanticscholar.org/3b08/26dcbbd38caa2a434d35b295af04c74c841b.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mikaeili</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fakhar</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sarkari</surname>
                            <given-names>B</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Comparison of serological methods (ELISA, DAT and IFA) for diagnosis of visceral leishmaniasis utilizing an endemic strain.</article-title>
                    <source>

                        <italic toggle="yes">Iran J Immunol.</italic>
</source>
                    <year>2007</year>;<volume>4</volume>(<issue>2</issue>):<fpage>116</fpage>&#x2013;<lpage>121</lpage>.
                    <pub-id pub-id-type="pmid">17652852</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Shokri</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fakhar</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Teshnizi</surname>
                            <given-names>SH</given-names>
                        </name>
</person-group>:
                    <article-title>Canine visceral leishmaniasis in Iran: A systematic review and meta-analysis.</article-title>
                    <source>

                        <italic toggle="yes">Acta Trop.</italic>
</source>
                    <year>2017</year>;<volume>165</volume>:<fpage>76</fpage>&#x2013;<lpage>89</lpage>.
                    <pub-id pub-id-type="pmid">27570207</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.actatropica.2016.08.020</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Molaei</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Dalimi</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mohebali</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Study of Canine Visceral Leishmaniasis in Symptomatic and Asymptomatic Domestic Dogs in Meshkinshahr City, Iran.</article-title>
                    <source>

                        <italic toggle="yes">J Ardabil Univ Med Sci.</italic>
</source>
                    <year>2016</year>;<volume>16</volume>(<issue>1</issue>):<fpage>105</fpage>&#x2013;<lpage>115</lpage>(Persian).
                    <ext-link ext-link-type="uri" xlink:href="http://jarums.arums.ac.ir/article-1-1049-en.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mohebali</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Edrissian</surname>
                            <given-names>GH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Shirzadi</surname>
                            <given-names>MR</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Integrated visceral leishmaniasis surveillance system in primary care for children in Meshkin-Shahr district, north-western Islamic Republic of Iran.</article-title>
                    <source>

                        <italic toggle="yes">East Mediterr Health J.</italic>
</source>apps.who.int.<year>2010</year>;<volume>16</volume>(<issue>10</issue>):<fpage>1050</fpage>&#x2013;<lpage>4</lpage>.
                    <pub-id pub-id-type="pmid">21222421</pub-id>
                    <pub-id pub-id-type="doi">10.26719/2010.16.10.1050</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report48933">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.21218.r48933</article-id>
            <title-group>
                <article-title>Reviewer response for version 2</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Salehzadeh</surname>
                        <given-names>Aref</given-names>
                    </name>
                    <xref ref-type="aff" rid="r48933a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r48933a1">
                    <label>1</label>Department of Medical Entomology and Vector Control, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>24</day>
                <month>6</month>
                <year>2019</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Salehzadeh A</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport48933" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.15805.2"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The quality of the present version of the manuscript is good but there are some minor typographical errors. For instance: 
                <list list-type="bullet">
                    <list-item>
                        <p>Please check and correct the sentence &#x201c; The role of domestic or stray dogs and Phlebotominae sand flies in the transmission cycle of the disease in clear&#x201d;&#x00a0; in line 21-22 of the fourth paragraph of the discussion section.</p>
                    </list-item>
                    <list-item>
                        <p>Please check and correct the word &#x00a0;&#x201c;congenital&#x201d; in line 14 of the 5
                            <sup>th</sup> paragraph of the discussion section</p>
                    </list-item>
                </list> Please clarify which types of Amphotericin-B has been used (liposomal or &#x2026;)</p>
            <p> Also, in line 4 of the 3
                <sup>rd</sup> paragraph of discussion please add one or two related references.</p>
            <p>Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?</p>
            <p>Partly</p>
            <p>Is the background of the cases&#x2019; history and progression described in sufficient detail?</p>
            <p>Partly</p>
            <p>Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?</p>
            <p>Yes</p>
            <p>Is the conclusion balanced and justified on the basis of the findings?</p>
            <p>No</p>
            <p>Reviewer Expertise:</p>
            <p>NA</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report48934">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.21218.r48934</article-id>
            <title-group>
                <article-title>Reviewer response for version 2</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Bar&#x00e7;ante</surname>
                        <given-names>Joziana Muniz de Paiva</given-names>
                    </name>
                    <xref ref-type="aff" rid="r48934a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <contrib contrib-type="author">
                    <name>
                        <surname>Bar&#x00e7;ante</surname>
                        <given-names>Thales</given-names>
                    </name>
                    <xref ref-type="aff" rid="r48934a1">1</xref>
                    <role>Co-referee</role>
                </contrib>
                <aff id="r48934a1">
                    <label>1</label>Department of Health Sciences, Federal University of Lavras (UFLA), Lavras, Brazil</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>6</day>
                <month>6</month>
                <year>2019</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Bar&#x00e7;ante JMdP and Bar&#x00e7;ante T</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport48934" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.15805.2"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?</p>
            <p>Partly</p>
            <p>Is the background of the cases&#x2019; history and progression described in sufficient detail?</p>
            <p>Partly</p>
            <p>Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?</p>
            <p>Partly</p>
            <p>Is the conclusion balanced and justified on the basis of the findings?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Parasitology</p>
            <p>We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report45651">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.17252.r45651</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Bar&#x00e7;ante</surname>
                        <given-names>Joziana Muniz de Paiva</given-names>
                    </name>
                    <xref ref-type="aff" rid="r45651a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r45651a1">
                    <label>1</label>Department of Health Sciences, Federal University of Lavras (UFLA), Lavras, Brazil</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>25</day>
                <month>4</month>
                <year>2019</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2019 Bar&#x00e7;ante JMdP</copyright-statement>
                <copyright-year>2019</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport45651" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.15805.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Leishmaniasis is considered an important zoonotic disease worldwide. So, the publication is relevant. Some aspects might be considered before the indexing of the manuscript:&#x00a0; 
                <list list-type="order">
                    <list-item>
                        <p>Is necessary a revision regarding correct biological concepts and terms. The first phrase of introduction is not correct. Third paragraph: 13.15% of total leismaniasis instead of Leishmania.</p>
                    </list-item>
                    <list-item>
                        <p>Is necessary a better description of the Figure 1. Also, in the legend, indicating the enlargement&#x00a0;of the spleen.&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>Is it necessary to include a image of amastigota identified in case 2.&#x00a0;</p>
                    </list-item>
                    <list-item>
                        <p>The authors should better explore the conclusion.</p>
                    </list-item>
                </list>
            </p>
            <p>Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?</p>
            <p>Partly</p>
            <p>Is the background of the cases&#x2019; history and progression described in sufficient detail?</p>
            <p>Partly</p>
            <p>Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?</p>
            <p>Partly</p>
            <p>Is the conclusion balanced and justified on the basis of the findings?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Parasitology</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report37818">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.17252.r37818</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Salehzadeh</surname>
                        <given-names>Aref</given-names>
                    </name>
                    <xref ref-type="aff" rid="r37818a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r37818a1">
                    <label>1</label>Department of Medical Entomology and Vector Control, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>5</day>
                <month>9</month>
                <year>2018</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2018 Salehzadeh A</copyright-statement>
                <copyright-year>2018</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport37818" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.15805.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The table is not acceptable in present form and should be corrected accurately by an expert physician, for example, the platelet &#x00a0;number should be shown per ml (mm3), the leukocytes count should be present as number per ml, or hemoglobin level by g/dl.</p>
            <p> The authors should include a figure of bone marrow smear. The bone marrow aspirate is the gold standard for confirming diagnosis. A definite diagnosis requires the demonstration of the parasites in tissue smears of the affected organs.</p>
            <p> </p>
            <p> The details of patients are very brief and has been not described precisely for instance&#x00a0; in second paragraph of discussion authors have argued that &#x201c;the cases were referred to hospital more than two months after the onset of symptoms&#x201d; whereas such information is not seen in description of case one in page 3.</p>
            <p> Did the authors check the possibility of cutaneous leishmaniasis, tuberculosis and malaria infections in patients?</p>
            <p> What about 
                <bold>congenital</bold> transmission?&#x00a0; Did the authors check mothers? &#x00a0;Because there are evidences that vertical transmission &#x00a0;might occur either transplacentally during pregnancy (in utero) or, most likely, during labor via blood exchange from the mother to the child (although in the vast majority of congenitally infected children, the symptoms and signs of VL develops during the first 12 months of life)</p>
            <p> Discussion is weak and should be rewritten and I cannot approve the manuscript in this form.</p>
            <p>Are enough details provided of any physical examination and diagnostic tests, treatment given and outcomes?</p>
            <p>Partly</p>
            <p>Is the background of the cases&#x2019; history and progression described in sufficient detail?</p>
            <p>Partly</p>
            <p>Is sufficient discussion included of the importance of the findings and their relevance to future understanding of disease processes, diagnosis or treatment?</p>
            <p>Yes</p>
            <p>Is the conclusion balanced and justified on the basis of the findings?</p>
            <p>No</p>
            <p>Reviewer Expertise:</p>
            <p>NA</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment4378-37818">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Zanjirani Farahani</surname>
                            <given-names>Leyli</given-names>
                        </name>
                        <aff>Tehran University of Medical Sciences, Iran</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>26</day>
                    <month>1</month>
                    <year>2019</year>
                </pub-date>
            </front-stub>
            <body>
                <p>Referee response:</p>
                <p> 1-The table is not acceptable in present form and should be corrected accurately by an expert physician, for example, the platelet number should be shown per ml (mm3), the leukocytes count should be present as number per ml, or hemoglobin level by g/dl.</p>
                <p> Many thanks for your comment, we will correct the table as you mentioned.</p>
                <p> </p>
                <p> 2-The authors should include a figure of bone marrow smear. The bone marrow aspirate is the gold standard for confirming diagnosis. A definite diagnosis requires the demonstration of the parasites in tissue smears of the affected organs.</p>
                <p> Thanks for your comment, we agree you in this matter. But because of the onset of this manuscript after the patient recovery and they were discharged from the hospital, no figure of bone marrow slide was obtained while diagnosing leishmaniasis. Since the blood smears are saved in the laboratory archive, we can photograph them and add it to the article with the editor approve.</p>
                <p> </p>
                <p> 3-The details of patients are very brief and has been not described precisely for instance&#x00a0; in second paragraph of discussion authors have argued that &#x201c;the cases were referred to hospital more than two months after the onset of symptoms&#x201d; whereas such information is not seen in description of case one in page 3.</p>
                <p> Regarding your comment, the parents of patients had visited various physicians at the onset of the disease symptoms and unfortunately, they had no complete report of these visits. For this reason, the data before being admitted to the Hospital is not complete.</p>
                <p> </p>
                <p> 4-Did the authors check the possibility of cutaneous leishmaniasis, tuberculosis and malaria infections in patients?</p>
                <p> Many thanks for your precision, we have discussed this issue in paragraph 4 of the discussion. Because of the possible interaction between some diseases such as malaria, tuberculosis and cutaneous leishmaniasis and VL diagnosis via DAT, the physicians had assessed it in primary examinations. Also there was no history of Kala-azar in the patients family members.</p>
                <p> </p>
                <p> 5-What about&#x00a0;
                    <bold>congenital</bold>&#x00a0;transmission?&#x00a0; Did the authors check mothers? &#x00a0;Because there are evidences that vertical transmission&#x00a0;might occur either trans placental during pregnancy (in utero) or, most likely, during labor via blood exchange from the mother to the child (although in the vast majority of congenitally infected children, the symptoms and signs of VL develops during the first 12 months of life)</p>
                <p> As you mentioned, it would be important in the first 12 months of the life. But patients described here are older than two years. However, we would like to inform you that there was no history of Kala-azar in the family members of children.</p>
                <p> Respecting your comment, it should be noted that the antigen used in DAT method is prepared using 
                    <italic>Leishmania infantum,</italic> which is the agent of the Mediterranean Leishmaniasis and causes the disease in children. The probability of Mediterranean Leishmaniasis in an adult and congenital&#x00a0;transmission with this high antibody titer at 2 years of age seems unlikely.</p>
                <p> </p>
                <p> 6-Discussion is weak and should be rewritten and I cannot approve the manuscript in this form.</p>
                <p> Thanks for your valuable guidance. We would appreciate if you could help us with the shortcomings in the article's discussion. Since this manuscript is important due to reporting VL cases in urban areas of Qom province, central Iran, which had not been reported for long, we will do our best to complete the discussion and convince you.</p>
            </body>
        </sub-article>
        <sub-article article-type="response" id="comment4717-37818">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Zanjirani Farahani</surname>
                            <given-names>Leyli</given-names>
                        </name>
                        <aff>Tehran University of Medical Sciences, Iran</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>3</day>
                    <month>7</month>
                    <year>2019</year>
                </pub-date>
            </front-stub>
            <body>
                <p>Dear Dr. Aref Salehzadeh,</p>
                <p> </p>
                <p> Many thanks for your precious comments on our article. Here are our respond to your latest comments:</p>
                <p> </p>
                <p> 1-Please check and correct the sentence &#x201c;The role of domestic or stray dogs and Phlebotominae sand flies in the transmission cycle of the disease in clear&#x201d; in line 21-22 of the fourth paragraph of the discussion section.</p>
                <p> The mistake is corrected.</p>
                <p> </p>
                <p> 2-Please check and correct the word&#x00a0;&#x201c;congenital&#x201d; in line 14 of the 5th&#x00a0;paragraph of the discussion section.</p>
                <p> We checked the word &#x201c;congenital&#x201d; in the dictionary and on the internet but it seems correct, respecting your opinion.</p>
                <p> </p>
                <p> 3-Please clarify which types of Amphotericin-B has been used (liposomal or &#x2026;).</p>
                <p> Since the liposomal form of Amphotericin-B is known as &#x201c;AmBisome&#x00ae;&#x201d; we didn&#x2019;t explain about the type of used Amphotericin-B in treatment of the patients.</p>
                <p> </p>
                <p> 4-In line 4 of the 3rd&#x00a0;paragraph of discussion please add one or two related references.</p>
                <p> Respecting your comment, there is only a report of both patients history in the mentioned lines which does not need any reference.</p>
            </body>
        </sub-article>
    </sub-article>
</article>
